Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

31 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV, Kenemans P, van Kamp GJ, Verstraeten AA, Hilgers J. Gourevitch MM, et al. Br J Cancer. 1995 Oct;72(4):934-8. doi: 10.1038/bjc.1995.436. Br J Cancer. 1995. PMID: 7547243 Free PMC article.
CA 125 half-life in ovarian cancer: a multivariate survival analysis.
Yedema CA, Kenemans P, Voorhorst F, Bon G, Schijf C, Beex L, Verstraeten A, Hilgers J, Vermorken J. Yedema CA, et al. Br J Cancer. 1993 Jun;67(6):1361-7. doi: 10.1038/bjc.1993.252. Br J Cancer. 1993. PMID: 8512822 Free PMC article.
Tenascin expression in basal cell carcinoma.
Verstraeten AA, Mackie EJ, Hageman PC, Hilgers J, Schol DJ, De Jongh GJ, Schalkwijk J. Verstraeten AA, et al. Br J Dermatol. 1992 Dec;127(6):571-4. doi: 10.1111/j.1365-2133.1992.tb14867.x. Br J Dermatol. 1992. PMID: 1282358
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
Snijdewint FG, von Mensdorff-Pouilly S, Karuntu-Wanamarta AH, Verstraeten AA, van Zanten-Przybysz I, Hummel P, Nijman HW, Kenemans P, Hilgers J. Snijdewint FG, et al. Among authors: verstraeten aa. Cancer Immunol Immunother. 1999 Apr;48(1):47-55. doi: 10.1007/s002620050547. Cancer Immunol Immunother. 1999. PMID: 10235488
An enzyme-linked immunosorbent assay for the measurement of circulating antibodies to polymorphic epithelial mucin (MUC1).
von Mensdorff-Pouilly S, Gourevitch MM, Kenemans P, Verstraeten AA, van Kamp GJ, Kok A, van Uffelen K, Snijdewint FG, Paul MA, Meijer S, Hilgers J. von Mensdorff-Pouilly S, et al. Among authors: verstraeten aa. Tumour Biol. 1998;19(3):186-95. doi: 10.1159/000030006. Tumour Biol. 1998. PMID: 9591045
Estimation of probability of malignancy using a logistic model combining physical examination, ultrasound, serum CA 125, and serum CA 72-4 in postmenopausal women with a pelvic mass: an international multicenter study.
Schutter EM, Sohn C, Kristen P, Möbus V, Crombach G, Kaufmann M, Caffier H, Kreienberg R, Verstraeten AA, Kenemans P. Schutter EM, et al. Among authors: verstraeten aa. Gynecol Oncol. 1998 Apr;69(1):56-63. doi: 10.1006/gyno.1998.4942. Gynecol Oncol. 1998. PMID: 9570999 Clinical Trial.
Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.
von Mensdorff-Pouilly S, Gourevitch MM, Kenemans P, Verstraeten AA, Litvinov SV, van Kamp GJ, Meijer S, Vermorken J, Hilgers J. von Mensdorff-Pouilly S, et al. Eur J Cancer. 1996 Jul;32A(8):1325-31. doi: 10.1016/0959-8049(96)00048-2. Eur J Cancer. 1996. PMID: 8869094
Mucin-like carcinoma-associated antigen serum levels in patients with adenocarcinomas originating from ovary, breast and colon.
Bon GG, Verheijen RH, Zuetenhorst JM, van Kamp GJ, Verstraeten AA, Kenemans P. Bon GG, et al. Gynecol Obstet Invest. 1996;42(1):58-62. doi: 10.1159/000291890. Gynecol Obstet Invest. 1996. PMID: 8840180
Discordant serum CA 125 values in commercial immunoassays.
van Kamp GJ, Verstraeten AA, Kenemans P. van Kamp GJ, et al. Eur J Obstet Gynecol Reprod Biol. 1993 Apr;49(1-2):99-103. doi: 10.1016/0028-2243(93)90132-v. Eur J Obstet Gynecol Reprod Biol. 1993. PMID: 8365530
The second generation CA 125 assays.
Kenemans P, Verstraeten AA, van Kamp GJ, von Mensdorff-Pouilly S. Kenemans P, et al. Ann Med. 1995 Feb;27(1):107-13. doi: 10.3109/07853899509031945. Ann Med. 1995. PMID: 7741988
31 results
Jump to page
Feedback